Hepatitis B ultrasound: Difference between revisions
Jump to navigation
Jump to search
Joao Silva (talk | contribs) No edit summary |
Joao Silva (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Hepatitis B}} | {{Hepatitis B}} | ||
{{CMG}} | {{CMG}}; {{AE}} {{JS}} | ||
==Overview== | ==Overview== | ||
==Ultrasound== | ==Ultrasound== | ||
[[Ultrasound]] may be used as a [[screening]] tool in patients with [[chronic hepatitis]] for early detection of [[hepatic cirrhosis]]. | [[Ultrasound]] may be used as a [[screening]] tool in patients with [[chronic hepatitis]] for early detection of [[hepatic cirrhosis]]. | ||
Revision as of 21:25, 30 July 2014
|
Hepatitis B |
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Hepatitis B ultrasound On the Web |
|
American Roentgen Ray Society Images of Hepatitis B ultrasound |
|
Risk calculators and risk factors for Hepatitis B ultrasound |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2]
Overview
Ultrasound
Ultrasound may be used as a screening tool in patients with chronic hepatitis for early detection of hepatic cirrhosis.
The following findings may be identified:
- Coarse echogenicity
- Segmental hypertrophy with nodular appearance of liver
- Portal hypertension:
HBsAg carriers should have regular serial serum AFP determinations and ultrasound examinations (at 6 months intervals for those above 40 years). Both these tests are recommended to be repeated regularly for all HBsAg carriers with cirrhosis.[1]
